Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Sell
32
PLSE Quote, Financials, Valuation and Earnings
Last price:
$13.48
Seasonality move
:
10.1%
Day range:
$13.20 - $13.88
52-week range:
$12.56 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10,177.90x
P/B ratio:
9.63x
Volume:
84.3K
Avg. volume:
162.4K
1-year change:
-31.7%
Market cap:
$892.7M
Revenue:
--
EPS (TTM):
-$1.14
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
$500K | -- | -- | -- | $22.00 |
|
EW
Edwards Lifesciences Corp.
|
$1.5B | $0.59 | 11.11% | -5.53% | $95.37 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.5M | -- | -57.12% | -57.14% | $2.23 |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
SINT
SINTX Technologies, Inc.
|
$200K | -$0.55 | -74.97% | -92.1% | $16.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
$13.27 | $22.00 | $892.7M | -- | $0.00 | 0% | 10,177.90x |
|
EW
Edwards Lifesciences Corp.
|
$84.32 | $95.37 | $48.9B | 35.90x | $0.00 | 0% | 8.43x |
|
IVF
INVO Fertility, Inc.
|
$1.54 | -- | $23.3M | -- | $0.00 | 0% | 0.03x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.71 | $2.23 | $35.6M | -- | $0.00 | 0% | 2.60x |
|
NTRB
Nutriband, Inc.
|
$4.82 | $15.00 | $57.9M | -- | $0.00 | 0% | 20.81x |
|
SINT
SINTX Technologies, Inc.
|
$4.03 | $16.75 | $15.5M | -- | $0.00 | 0% | 6.83x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
7.84% | 1.721 | 0.66% | 9.82x |
|
EW
Edwards Lifesciences Corp.
|
6.42% | -0.140 | 1.55% | 2.86x |
|
IVF
INVO Fertility, Inc.
|
41.99% | -0.446 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.49% | 2.039 | 0.87% | 5.64x |
|
NTRB
Nutriband, Inc.
|
3.08% | 2.796 | 0.31% | 4.55x |
|
SINT
SINTX Technologies, Inc.
|
45.47% | 1.079 | 22.94% | 1.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
-$449K | -$20.4M | -67.74% | -73.32% | -23682.56% | -$13.1M |
|
EW
Edwards Lifesciences Corp.
|
$1.2B | $433.1M | 12.34% | 13.19% | 27.89% | $516.2M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$914.8K | -$1.9M | -151.86% | -166.02% | -111.24% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$156.9K | -$2M | -114.42% | -117.44% | -321.8% | -$1.3M |
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
Pulse Biosciences, Inc. vs. Competitors
-
Which has Higher Returns PLSE or EW?
Edwards Lifesciences Corp. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of 18.82%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat Edwards Lifesciences Corp.'s return on equity of 13.19%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M EWEdwards Lifesciences Corp.78.29% $0.50 $10.9B -
What do Analysts Say About PLSE or EW?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 65.79%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $95.37 which suggests that it could grow by 13.11%. Given that Pulse Biosciences, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe Pulse Biosciences, Inc. is more attractive than Edwards Lifesciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 EWEdwards Lifesciences Corp.15 14 0 -
Is PLSE or EW More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.229%.
-
Which is a Better Dividend Stock PLSE or EW?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or EW?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than Edwards Lifesciences Corp.'s net income of $292.3M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 35.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,177.90x versus 8.43x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,177.90x -- $86K -$19.4M EWEdwards Lifesciences Corp.8.43x 35.90x $1.6B $292.3M
-
Which has Higher Returns PLSE or IVF?
INVO Fertility, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -150.51%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About PLSE or IVF?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 65.79%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 9250.65%. Given that INVO Fertility, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe INVO Fertility, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 IVFINVO Fertility, Inc.0 0 0 -
Is PLSE or IVF More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.
-
Which is a Better Dividend Stock PLSE or IVF?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or IVF?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,177.90x versus 0.03x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,177.90x -- $86K -$19.4M IVFINVO Fertility, Inc.0.03x -- $1.8M -$2.6M
-
Which has Higher Returns PLSE or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -88.5%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat NeuroOne Medical Technologies Corp.'s return on equity of -166.02%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M NMTCNeuroOne Medical Technologies Corp.53.94% -$0.03 $8.5M -
What do Analysts Say About PLSE or NMTC?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 65.79%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 212.5%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Pulse Biosciences, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is PLSE or NMTC More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.
-
Which is a Better Dividend Stock PLSE or NMTC?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or NMTC?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $1.7M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.5M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,177.90x versus 2.60x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,177.90x -- $86K -$19.4M NMTCNeuroOne Medical Technologies Corp.2.60x -- $1.7M -$1.5M
-
Which has Higher Returns PLSE or NTRB?
Nutriband, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -321.33%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat Nutriband, Inc.'s return on equity of -117.44%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M NTRBNutriband, Inc.25.21% -$2.12 $8.8M -
What do Analysts Say About PLSE or NTRB?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 65.79%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 211.2%. Given that Nutriband, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe Nutriband, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 NTRBNutriband, Inc.1 0 0 -
Is PLSE or NTRB More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock PLSE or NTRB?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or NTRB?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than Nutriband, Inc. quarterly revenues of $622.5K. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than Nutriband, Inc.'s net income of -$2M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,177.90x versus 20.81x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,177.90x -- $86K -$19.4M NTRBNutriband, Inc.20.81x -- $622.5K -$2M
-
Which has Higher Returns PLSE or SINT?
SINTX Technologies, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -1701.44%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat SINTX Technologies, Inc.'s return on equity of -208.36%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M -
What do Analysts Say About PLSE or SINT?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 65.79%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $16.75 which suggests that it could grow by 315.63%. Given that SINTX Technologies, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 SINTSINTX Technologies, Inc.2 0 0 -
Is PLSE or SINT More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.
-
Which is a Better Dividend Stock PLSE or SINT?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or SINT?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than SINTX Technologies, Inc. quarterly revenues of $208K. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,177.90x versus 6.83x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,177.90x -- $86K -$19.4M SINTSINTX Technologies, Inc.6.83x -- $208K -$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
56
SMX alert for Dec 9
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Sell
45
GPCR alert for Dec 9
Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.
Buy
72
KYMR alert for Dec 9
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
